https://www.selleckchem.com/pr....oducts/ZM-447439.htm
The aim of this study was to explore the role of pioglitazone (PIO), a peroxisome proliferator-activated receptor-gamma (PPARγ) agonist, in cardiac fibrosis of diabetic mice. A total of 60 adult male C57/B6 mice were divided into 3 groups using a random number table, namely, control group (Sham group, n=2, diabetic cardiomyopathy group (DCM group, n=2, DCM + PIO group (n=2. Streptozocin (STZ) was injected into mice at a dose of 125 mg/Kg to induce the model of diabetes in vivo. After successful induction, mice in DCM + PIO group
Like
Comment
Share
